Across various classes, the researchers identified a model that, when coupled with appropriate data augmentation and ...

Proposed Medicaid cuts in the Republican budget proposal hold significant implications for health care access and coverage.

Researchers hope that identifying the genomic alterations specific to transformed small cell lung cancer (SCLC) can help ...

The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial ...

Upadacitinib shows sustained efficacy and consistent safety for moderate to severe ulcerative colitis in long-term trials and ...

Stephen Speicher, MD, and Kate Estep, from Flatiron Health, discuss the future of oncology care with artificial intelligence ...

The move would align prescription costs in the US with the costs of other countries, according to the administration.

A panelist discusses how guidelines from organizations like the National Comprehensive Cancer Network (NCCN) can improve ...

A panelist discusses how tumor heterogeneity (both spatial and temporal) affects molecular testing reliability in ovarian ...

Panelists discuss how matching-adjusted indirect comparisons (MAIC) of ALK inhibitors and the FDA approval of ensartinib in ...

Panelists discuss how clinical trial outcomes like CROWN and eXalt3 reflect real-world patient experiences and how these ...

First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of ...